Differentiation of macrophages from myeloid progenitor cells depends on a discrete balance between cell growth, survival, and differentiation signals. Interleukin-8 (IL-3) supports the growth and survival of myeloid progenitor cells through the activation of Jak2 tyrosine kinase, and macrophage differentiation has been shown to be regulated by protein kinase C (PKC). During terminal differentiation of macrophages, the cells lose their mitogenic response to IL-3 and undergo growth arrest, but the underlying signaling mechanisms have remained elusive. Here we show that in IL-3-dependent 32D myeloid progenitor cells, the differentiation-inducing PKC isoforms PKC-(C) 2000 by The American Society of Hematology alpha and PKC-delta specifically caused rapid inhibition of IL-3-induced tyrosine phosphorylation. The target for this inhibition was Jak2, and the activation of PKC by 12-O-tetradecanoyl-phorbol-13-acetate treatment also abrogated Ii-a-induced tyrosine phosphorylation of Jak2 in Ba/F3 cells, The mechanism of this regulation was investigated in 32D and COS7 cells, and the inhibition of Jak2 required catalytic activity of PKC-delta and involved the phosphorylation of Jak2 on serine and threonine residues by the associated PKC-delta, Furthermore, PKC-delta inhibited the in vitro catalytic activity of Jak2, indicating that Jak2 was a direct target for PKC-delta In 32D cells, the inhibition of Jak2 either by PKC-delta, tyrosine kinase inhibitor AG490, or IL-3 deprivation caused a similar growth arrest. Reversal of PKC-delta-mediated inhibition by the overexpression of Jak2 promoted apoptosis in differentiating 32D cells. These results demonstrate a PKC-mediated negative regulatory mechanism of cytokine signaling and Jak2, and they suggest that it serves to integrate growth-promoting and differentiation signals during macrophage differentiation. (C) 2000 by The American Society of Hematology.
机构:
Univ British Columbia, Vancouver, BC V5Z 1M9, CanadaBritish Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
Muranyi, Andrew L.
Dedhar, Shoukat
论文数: 0引用数: 0
h-index: 0
机构:
Univ British Columbia, Vancouver, BC V5Z 1M9, CanadaBritish Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
Dedhar, Shoukat
Hogge, Donna E.
论文数: 0引用数: 0
h-index: 0
机构:
British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
Univ British Columbia, Vancouver, BC V5Z 1M9, CanadaBritish Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
机构:
ED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia
Natl Res Tomsk State Univ, Tomsk, RussiaED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia
Zyuz'kov, G. N.
Zhdanov, V. V.
论文数: 0引用数: 0
h-index: 0
机构:
ED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, RussiaED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia
Zhdanov, V. V.
Udut, E. V.
论文数: 0引用数: 0
h-index: 0
机构:
ED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, RussiaED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia
Udut, E. V.
Miroshnichenko, L. A.
论文数: 0引用数: 0
h-index: 0
机构:
ED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, RussiaED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia
Miroshnichenko, L. A.
Simanina, E. V.
论文数: 0引用数: 0
h-index: 0
机构:
ED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, RussiaED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia
Simanina, E. V.
Polyakova, T. Yu.
论文数: 0引用数: 0
h-index: 0
机构:
ED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, RussiaED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia
Polyakova, T. Yu.
Chaikovskii, A. V.
论文数: 0引用数: 0
h-index: 0
机构:
ED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, RussiaED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia
Chaikovskii, A. V.
Stavrova, L. A.
论文数: 0引用数: 0
h-index: 0
机构:
ED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, RussiaED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia
Stavrova, L. A.
Udut, V. V.
论文数: 0引用数: 0
h-index: 0
机构:
Natl Res Tomsk State Univ, Tomsk, RussiaED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia
Udut, V. V.
Agafonov, V. I.
论文数: 0引用数: 0
h-index: 0
机构:
ED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, RussiaED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia
Agafonov, V. I.
Burmina, Ya. V.
论文数: 0引用数: 0
h-index: 0
机构:
ED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, RussiaED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia
Burmina, Ya. V.
Danilets, M. G.
论文数: 0引用数: 0
h-index: 0
机构:
ED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, RussiaED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia
Danilets, M. G.
Minakova, M. Yu.
论文数: 0引用数: 0
h-index: 0
机构:
ED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, RussiaED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia
Minakova, M. Yu.
Dygai, A. M.
论文数: 0引用数: 0
h-index: 0
机构:
ED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, RussiaED Goldberg Res Inst Pharmacol & Regenerat Med, Tomsk, Russia